Brief: Royal Bank Of Canada's Long Position In H-Share Of Shanghai Haohai Biological Rises To 5.06% - HFiling

Shanghai Haohai Biological Technology

07/04/2022 10:06

April 7 (Reuters) - Hong Kong stock exchange filing:
    * ROYAL BANK OF CANADA BOUGHT 54,600 H-SHARE OF SHANGHAI
HAOHAI
BIOLOGICAL  6826.HK  AT AVG PRICE OF HK$40.2  ($5.13) PER SHARE
ON APRIL 1 - HKEX FILING
    * ROYAL BANK OF CANADA'S LONG POSITION IN H-SHARE OF
SHANGHAI
HAOHAI BIOLOGICAL RISES TO 5.06% FROM 4.92% - HKEX FILING

Source text https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20220406E00537&sa2=ns&sid=119410&sd=07/04/2021&ed=07/04/2022&sa1=cl&scsd=07/04/2021&sced=07/04/2022&sc=06826&src=Main&lang=EN&tk=ds
Further company coverage:  6826.HK 

($1 = 7.8371 Hong Kong dollars)

 (Reporting by Hong Kong newsroom)
 ((twinnie.siu@tr.com; 852-3462 7715;))